Planck Institute of Molecular Plant Physiology developed a novel strategy to identify protein-molecules that have regulatory functions in stress reduction
Cinderella of chemical biology
Cinderella of chemical biology
The HealthCapital Cluster Berlin and the Interest Group Biotechnology of the German Association of Research Based Pharmaceutical Companies (vfa bio) will award the most captivating research pitches at this year´s BIONNALE 2022.
Young scientists…
ProBioGen was founded in Berlin in 1994, and has been part of the Egyptian Minapharm Group since 2010. The biotech company and its subsidiary MiGenTra operate around the globe and have years of experience developing and producing biopharmaceuticals…
- Funding round supported by High-Tech Gründerfonds (HTGF), Brandenburg Kapital and several private investors, showing their continued commitment
- Funds to be mainly used to complete ongoing REMOVE study with CATUVAB®, extend clinical program,…
Reinforcement agreed with Livit, one of the leading patient care providers in the Netherlands
Cell-based medicine has the potential to detect and counteract diseases long before symptoms become apparent. This comparatively young medical approach uses a large number of new technologies to achieve this. The Berlin Cell Hospital, which is newly…
From Berlin-Tempelhof to the whole world: TIB Molbiol employees developed the world’s first corona test. In the meantime, millions of people have been tested with the kits and the orders don’t stop coming in. Long-standing partner Roche recently…
Charité retains its longstanding position at the top of the rankings.
Sanofi is now accepting submissions for the 2022 Sanofi Golden Ticket Competition!
Sanofi is a global sponsor of BioLabs, a premier shared laboratory space for life science and biotech startups to test new ideas and innovate. …
Researchers from the Experimental Pharmacology and Oncology (EPO) in Berlin-Buch in cooperation with academic partners identified new experimental approaches to treat therapy resistant cancer.
Patients with advanced colon cancer have limited…